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Summary
Spinal muscular atrophy (SMA), the leading genetic disorder of infant mortality, is caused by low levels of survival motor neuron (SMN) protein. Currently it is not clear how the SMN protein levels are regulated at the posttranscriptional level. In this report, we find that Usp9x, a deubiquitinating enzyme, stably associates with the SMN complex via directly interacting with SMN. Usp9x deubiquitinates SMN that is mostly mono-and di-ubiquitinated. Knockdown of Usp9x promotes SMN degradation and reduces the protein levels of SMN and the SMN complex in cultured mammalian cells. Interestingly, Usp9x does not deubiquitinate nuclear SMN∆7, the main protein product of the SMN2 gene, which is polyubiquitinated and rapidly degraded by the proteasome. Together, our results indicate that SMN and SMN∆7 are differently ubiquitinated; Usp9x plays an important role in stabilizing SMN and the SMN complex, likely via antagonizing Ub-dependent SMN degradation.
Spinal muscular atrophy (SMA), an autosomal recessive disorder that results in degeneration of α-motor neurons in the spinal cord, is the leading hereditary disease causing infant mortality (1) (2) (3) . SMA is caused by homozygous deletions or mutations in the survival motor neuron 1 gene (SMN1) (4) . The vast majority of SMA (> 95%) is caused by SMN1 deletion (4;5). Humans have two SMN genes, both the telomeric SMN1 and the centromeric SMN2 encode full-length SMN protein (294 amino acids). However, a C to T nucleotide change at the +6 position of exon 7 in SMN2 usually causes exclusion of exon 7 during splicing and only approximately 15% of full-length transcript is made (6) . SMA patients usually have one or more copies of SMN2. Studies have shown that the copy number of SMN2 inversely correlates with disease severity in human patients (4;5;7-9) . Mice have a single Smn gene, ablation of which results in early embryonic lethality (10) . Introduction of two copies of SMN2 in the Smn-null background rescues embryonic lethality, while mice with eight copies of SMN2 show complete rescue (11) . Thus, SMA is caused by low protein levels of SMN (12;13) .
SMN is widely expressed in all cell types of vertebrates and distributes in both the cytoplasm and the nucleus of cells (14) (15) (16) (17) . In the nucleus, SMN concentrates in punctate foci called gems, which usually co-localize with coilin in Cajal bodies (16) (17) (18) . SMN forms a stable complex with Gemins 2-8 and Unrip, termed the SMN complex (19) , in which Gemins 2, 3 and 8 directly interact with SMN (20) . A well-characterized function of the SMN complex is to help assembly and transport of uridine-rich small nuclear ribonucleoproteins (snRNPs) (21) (22) (23) (24) , core components of the spliceosome. SMN also interacts with a variety of other proteins (25) . A group of SMN-interacting proteins including profilin I and II, hnRNP-R and plastin 3 are involved in regulating β-actin mRNA transport or actin dynamics in axons (25) , which regulates neuronal growth. Particularly, SMN deficient motor neurons, derived from severe SMA mice, were found to have reduced localization of β-actin mRNA in axons and reduced protein levels of β-actin in axonal growth cones (26) . Accordingly, splicing defects of a group of transcripts that are critical for α-motor neuron survival and impairment of β-actin mRNA transport and localization were hypothesized to explain SMA pathogenesis (25;27;28) . Currently, direct evidence that supports either hypothesis is still lacking. SMN∆7, the protein product of the SMN2 transcript with exon 7 exclusion, lacks the C-terminal 16 amino acids of SMN, but has four extra amino acids (EMLA) because of a frame shift. SMN∆7 is barely detectable in cells or tissues derived from SMA human patients or mice, despite SMN∆7 mRNA being present at high levels. In agreement with this, SMN∆7 has a much shorter half life (approximately 2-3 hours) than that of wild type SMN (approximately 6-8 hours) (29) (30) (31) . One potential explanation is that SMN∆7 cannot self-associate to oligomerize and assemble into the SMN complex (29) . In addition, a recent study has shown that the C-terminal region of SMN∆7 functions as a degron to promote rapid SMN∆7 degradation (31) . Thus, degradation of SMN and SMN∆7 might be regulated differently in cells. It has been reported that SMN and SMN∆7 are substrates of the proteasome (29;31;32) , however little is known about the mechanism by which the ubiquitin (Ub)-proteasome system degrades SMN and SMN∆7.
Usp9x (2547 amino acids) is one of the largest DUBs belonging to the Ub-specific protease family (33) . Based on a bioinformatics study, Usp9x contains a Ub-like domain (amino acid 873-966) and a Ub C-terminal hydrolase domain (amino acid 1531-1971) that catalyzes deubiquitination (34;35) . Usp9x exhibits diverse DUB activities to deubiquitinate its substrates modified with monoUb or polyUb chains linked through lysine 29, 33, 48 or 63 of Ub. There are a dozen substrates of Usp9x having been identified including AF-6, β-catenin, NUAK1, MARK4, ErbB2, EFA6, Smad4, Mcl1, ASK1 and survivin (36) (37) (38) (39) (40) (41) (42) (43) (44) . In this study, we found that SMN is a substrate of Usp9x; Usp9x interacts with, deubiquitinates and stabilizes SMN that is mostly mono-and diubiquitinated. In contrast, Usp9x does not regulate SMN∆7's ubiquitination and stability; SMN∆7 can be polyubiquitinated and it is much more susceptible to proteasomal degradation than SMN.
Experimental Procedures Antibodies
The following antibodies were purchased: Usp9x, Gemin4 and Gemin5 (Bethyl Laboratories); SMN, Ub (P4D1) and Myc (9E10) (Santa Cruz Biotechnology); SMN, Gemin2, Gemin3 and coilin (BD Biosciences); Flag (M2), Gemin8 (1F8) and β-actin (AC-15) (Sigma); HA (16B12) (Covance). The Y12 antibody is a gift from D. Bentley (University of Colorado Denver).
Mammalian expression constructs
The cDNAs of full length human Usp9x and Usp9x(C1566A) were provided by Dr. D. R. Alessi (University of Dundee) (38) . We subcloned both Usp9x and Usp9x(C1556A) into the pRK5, pRK7 or pQCXIP-HTBH (45) vector using the BamH1 and NotI sites in the provided plasmids. Expression plasmids of SMN, Gemins 2-8, Unrip and Ub were constructed by PCR amplification of the corresponding open reading frames from a human 293T cDNA library using pfu polymerase (Stratagene) and subsequently subcloned into the pRK5 or pRK7 vector containing an N-terminal HA or FLAG tag (46) . All plasmids were validated by DNA sequencing. Cell culture and transfection Fibroblast cells derived from a normal carrier (GM03814) and two type I SMA patients (GM03813 and GM00232) were obtained from Coriell Cell Repositories.
Human embryonic kidney (HEK) 293T, HeLa and fibroblast cells were grown in DMEM supplemented with 10% fetal bovine serum (Sigma) and 100 µg/ml penicillin and streptomycin at 37 0 C in a 5% CO 2 atmosphere. Human neuroblastoma SH-SY5Y cells and lung adenocarcinoma epithelial A549 cells were maintained in DMEM/F12 (1:1) and F12 medium with 10% fetal bovine serum, respectively. 293T cells were grown to 50%-60% confluency and transfected using the standard calcium phosphate precipitation method (46) . Typically, 10 µg of plasmid was used for a single-gene transfection of a 100 mm dish of cells, up to 30 µg of plasmids were used for co-transfection of three plasmids. Transfection of HeLa cells was performed using the Lipofectamine 2000 (Invitrogen) or Turbofect (Fisher) transfection reagent according to the manufacturers' instructions. In assays with proteasome inhibition, 10 µM MG132 or epoxomicin was incubated with cells for 16 hours. Establishing Usp9x stable knockdown cell lines MISSION shRNAs of Usp9x (TRCN0000007361 and TRCN0000007364) and a control EGFP shRNA (SHC005) in pLKO.1 vector were purchased from the Functional Genomic Facility at the University of Colorado. To produce viruses, 293FT cells at 60-70% confluency were cotransfected with 5 µg of the corresponding shRNA pLKO.1-puro plasmid plus 2 µg of each of the packaging plasmids (Sigma) using Lipofectamine 2000. 16 hours post-transfection, medium was changed and cells were cultured for an additional 48 hours. The medium was then collected and centrifuged to remove cell debris and the supernatants were filtered through 0.22 µm membranes. The resulting virus-containing supernatants (5 ml) were used to infect the corresponding cells (60 mm dish) in medium supplemented with 8 µg/ml polybrene (Sigma) overnight. Cells were then selected with 2 µg/ml puromycin for at least five days.
Immunoprecipitation and immunoblotting assays
For non-denaturing immunoprecipitation, cells in a 100 mm dish (90% confluency) were harvested and washed with 1X PBS, then lysed with 1.5 ml cold cell lysis buffer (20 mM Tris, pH 7.6, 150 mM NaCl, 2 mM EDTA, 0.5% TX-100, 10% glycerol) with 1X protease inhibitor cocktail (Roche). After clearing the lysates by centrifugation, supernatants were incubated with 2 µg of an appropriate antibody or control IgG for four hours at 4 0 C, then supplemented with 20 µl protein A beads that were preincubated with 2 mg/ml BSA to reduce non-specific binding. After overnight rocking, protein A beads were pelleted by centrifugation and washed three times with the cell lysis buffer plus 0.6 M NaCl. Bound proteins were eluted with 50 µl 1X SDS sample buffer. For denaturing immunoprecipitation, HeLa cells in a 100 mm dish or 293T cells in a 60 mm dish were lysed into 1 ml cell lysis buffer plus 1% SDS. Cell lysates were collected and then heated at 95 0 C for 30 min. After centrifugation, 0.3 ml supernatants were diluted with 1.2 ml cell lysis buffer to reduce SDS concentration to 0.2%. The immunoprecipitation assay was performed as described above except that 5 µg anti-Flag M2 antibody or mouse IgG was used in each reaction. 20 µl elutions were resolved by SDS-PAGE and transferred to nitrocellulose membranes for immunoblotting assays.
Immunofluorescence staining and confocal microscopy
HeLa cells cultured on glass coverslips were fixed with 100% methanol at -20 0 C for 10 min and then blocked with blocking buffer (1% BSA in TTBS) for 1 hour. Cells were then incubated with an appropriate primary antibody (1:200-1:1000 dilution) in blocking buffer overnight at 4 0 C, followed by incubating with antimouse or rabbit IgG (H+L) (Alexa Fluor-488 or 555 Conjugate) (Cell Signaling) for 1 hour at room temperature. The coverslip was mounted with the ProLong® Gold Antifade kit (Invitrogen) containing the blue-fluorescent nuclear counterstain DAPI. The cells were observed and the images were captured using a Zeiss 3I Marianas spinning disk confocal microscope with a 63X oil immersion objective lens (Light Microscope Core, University of Colorado School of Medicine).
Protein purification
The cDNA coding region of SMN or SMN∆7 was subcloned into the NheI and XhoI sites of the pET-28a(+) vector. The plasmids were transformed into E. coli BL21 (DE3) cells. E. coli cells containing the expression plasmid were grown to an OD 600 = 0.6 at 37 0 C, protein expression was induced with 0.5 mM IPTG for induction of 5 hours. SMN or SMN∆7 protein was purified from cell pellets followed by refolding. Briefly, cell pellets from a 2 L culture were resuspended into 40 mL lysis buffer (20 mM Tris, pH 7.6,150 mM NaCl, 2 mM βME, 1X Leupeptin, 1X PMSF), followed by sonication and centrifugation at 30,000 Xg for 30 min at 4 0 C. Insoluble pellets were rinsed by lysis buffer and then resuspended in a denaturing buffer (10 mM Tris, pH 8.0, 6 M GndHCl). After sonication and centrifugation, supernatants were rocked with 5 ml Ni-NTA resins (Invitrogen) overnight. Resins were subsequently washed with a urea-containing denaturing buffer (10 mM Tris, pH 8.0, 6 M Urea) plus 25 mM imidazole, and proteins were eluted off Ni-NTA resins with the urea denaturing buffer plus 150 mM imidazole. The elutions were then loaded into a 20 mL Q-Sepharose column on an AKTA FPLC system (performed at room temperature). Proteins were eluted using a NaCl gradient from 0 to 250 mM in 20 mM Tris, pH 8.0, 5 M Urea. Corresponding fractions with SMN or SMN∆7 as judged by Coomassie-stained SDS-PAGE were pooled and dialyzed against arginine refolding buffer (1 M arginine, 100 mM Tris, pH 8.0, 100 mM NaCl,) at 4°C. After 36 hours dialysis (refolding), insoluble proteins were pelleted by centrifugation. Arginine was removed by dialyzing folded SMN or SMN∆7 into a storage buffer (20 mM Tris, pH 8.0, 250 mM NaCl, 2 mM βME and 10% glycerol).
The cDNA coding region of Usp9x was subcloned into the pYES-263 vector (47) using the BamHI and NotI sites. Expression plasmids were transformed into yeast strain RSY334 (MATα pep4-3 prb1-1122 ura3-52 leu2-3,112 reg1-501 gal1) (48) by the lithium acetate method by selection for Ura+ colonies. A 5 mL overnight culture (OD 600 = 0.7) from a single colony was inoculated into 1 L of -Ura selective media and grown to OD 600 = 0.25 (4.5 x 10 6 cells). Protein expression was induced by adding 2% galactose. Cultures were then shaken overnight at 30°C. Cells were harvested and cell pellets were washed with ice cold mili-Q H 2 O, followed by washing with ice cold grinding buffer (50 mM Tris, pH 7.6, 200 mM NaCl, 1 mM βME, 1 mM EDTA, 1 mM PMSF, 10% Glycerol). After centrifugation, cell pellets were resuspended in 15 ml grinding buffer and frozen with liquid nitrogen in a dropwise manner using a 1 ml pipet to prepare small frozen pellets. Pellets were then ground into dry powder using 6870 Freezer/Mill (SPEX SamplePrep). To purify GST-Usp9x, ground yeast powder from 3 L cultures were dissolved into 50 mL lysis buffer (20 mM Tris, pH 7.6, 1 mM βME, 1 mM EDTA, 10% glycerol, 1X PMSF, 1X Leupeptin) and centrifuged at 30,000 Xg for 30 min at 4°C. Supernatants were then ultracentrifuged at 90,000 Xg using a Ti-70.1 rotor for 60 min at 4 0 C. The resulting supernatants were then loaded into a 20 mL Q-Sepharose column equilibrated in the lysis buffer on an AKTA FPLC system. Proteins were eluted using a NaCl gradient from 0-400 mM NaCl. Fractions eluted between 275 and 350 mM NaCl were confirmed to contain Usp9x by immunoblotting. These fractions were pooled and NaCl concentration was raised to approximately 1 M. Next, the protein mixtures were rocked with 2 mL glutathione Sepharose at 4 °C for 4 hours. Resins were then loaded into a 10 ml open column and washed with 30 mL washing buffer (20 mM Tris, pH 7.6, 500 mM NaCl, 1 mM βME and 10% glycerol). GST-Usp9X was eluted with 10 mM glutathione and dialyzed into the washing buffer for storage.
Identification of Usp9x-interacting protein
To identify Usp9x-interacting proteins by mass spectrometry, Usp9x was purified from 293T cells stably expressing Usp9x-HTBH. 30 dishes (100 mm) of 293T cells stably expressing HTBH or Usp9x-HTBH were harvested and washed with 1X PBS. Cells were lysed into 30 ml lysis buffer (20 mM Tris, pH 7.6, 100 mM NaCl, 2 mM βME, 10% glycerol, 0.3% CHAPS and 1X protease inhibitor cocktail) by sonication. Cell lysates were cleared by ultracentrifugation (100,000 Xg) for 1 hour at 4 0 C. The supernatants were then mixed with 100 µl streptavidin resin (Fisher Scientific) and rocked at 4 0 C overnight. Resins were transferred into a 2 ml centrifugation tube and washed twice with 1.5 ml lysis buffer plus 0.2 M NaCl, followed by one wash with the elution buffer (20 mM Tris, pH 7.6, 100 mM NaCl, 2 mM βME). Resins were then transferred into a 0.65 ml centrifugation tube and resuspended into 150 µl elution buffer with 0.06 µg/µl TEV protease. After 4 hours rocking at room temperature, eluted proteins were assayed by SDS-PAGE with silver staining. 20 µl eluted proteins were subjected to mass spectroscopic analysis carried out on an optimized proteomics platform as previously reported (49) . Briefly, protein samples were resolved on a short SDS gel and stained with Coomassie, followed by in-gel digestion and peptide extraction. The resulting peptides were analyzed by a nanoscale reverse phase liquid chromatography coupled with an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific). The peptides were dissolved in buffer A (0.1% formic acid, 0.005% heptafluorobutyric acid and 5% acetonitrile), loaded onto a 75 µm i.d. x 10 cm column (HALO ® C 18 resin, 90 Å, 2.7 µm; tip size 15 µm; New Objective, MA), and then eluted during a 60-min gradient of 10-40% buffer B (0.1% formic acid, 0.005% heptafluorobutyric acid, 70% acetonitrile, flow rate of 250 nl/min). The eluted peptides were analyzed by a circling instrument method, including one MS survey scan and up to 10 data-dependent MS/MS scans. Acquired MS/MS spectra were searched against a human Uniprot database (www.uniprot.org) using the SEQUEST algorithm. Searching parameters included mass tolerance of precursor ions (±20 ppm) and product ion (±0.5 Da), tryptic restriction, dynamic mass shifts for oxidized Met (+15.9949), two maximal modification sites, two maximal missed cleavages, as well as only b and y ions counted. To evaluate false discovery rate during spectrum-peptide matching, all original protein sequences were reversed to generate a decoy database that was concatenated to the original database (50) . Assigned peptides were grouped by charge state and then filtered by matching scores (XCorr and deltaCn) to reduce protein false discovery rate to approximately 1%. If peptides were shared in a protein family, the family proteins were clustered into a single group. Based on the principle of parsimony, the group was represented by the protein with highest number of assigned peptides, and by other proteins if they were matched by unique peptide(s).
In vitro deubiquitination assay
K48-linked Ub 4 was purified as previously described (51) . To monitor Usp9x-mediated deubiquitination of K48 Ub 4 , 200 nM K48 Ub 4 was mixed with 10 nM Usp9x in the deubiquitination buffer (20 mM Tris, pH 7.6, 150 mM NaCl, 2 mM DTT and 10% glycerol) and incubated at 37 0 C. 20 µl reaction mixtures were withdrawn at designated time points and mixed with 5 µl 5X SDS sample buffer to stop the reaction. Deubiquitination was assayed by immunoblotting of Ub. To monitor Usp9x-mediated deubiquitination of SMN, cell lysates of three 100 mm dishes of 293T cells expressing Flag-SMN and HA-Ub were subjected to immunoprecipitation with the anti-Flag M2 antibody using the non-denaturing immunoprecipitation assay. Proteins immobilized on protein A beads were washed three times with the cell lysis buffer plus 0.5% TX-100 and 1.2 M NaCl. Protein A beads were then resuspended into 150 µl deubiquitination buffer and were equally split into three parts to set up the deubiquitination reactions: without Usp9x, with 10 nM Usp9x or 10 nM Usp9x + 2.5 µM Ub aldehyde (UBPBio). After 6 hours incubation at 30 0 C, reactions were stopped by adding 5X SDS sample buffer. Deubiquitination was monitored by immunoblotting using an anti-HA or Flag antibody.
Supplemental materials
Supplemental materials include eight figures and figure legends.
Results

Usp9x interacts with the SMN complex
In an effort to identify Usp9x-interacting proteins, we established 293T cell lines stably expressing Flag-HTBH or Flag-Usp9x-HTBH ( Fig. 1A and  B) . The HTBH tag consists of a 6xHis, a TEV protease sequence, an in vivo Biotinylation sequence and another 6xHis (45) . Usp9x was enriched from cell lysates with streptavidin resin, and then released by TEV protease digestion (Fig. 1C) . Proteins co-purified with Usp9x were identified by mass spectrometry. Among the identified proteins, peptides of five components of the SMN complex were identified (Fig. 1D and Fig. S1 ). In reminiscence of a recent proteomic study in which Usp9x was found to interact with GFP-SMN (52), we speculated that Usp9x interacts with the SMN complex. Indeed, components of the SMN complex including SMN, Gemins 2, 3, 4 and 8 existed in the Usp9x precipitates, but not in the control one as assayed by immunoblotting (Fig. 1E) . In addition, components of the Sm complex that interacts with the SMN complex were also detected with the Y12 antibody (Fig. 1E) , which recognizes SmB'/B and SmD subunits of the heptameric Sm complex (53) . Thus, the SMN/Sm complex copurified with Usp9x. To determine whether Usp9x interacts with the SMN complex under physiological conditions, we immunoprecipitated endogenous SMN in HeLa cells and found that Usp9x co-immunoprecipitated with SMN and other components of the SMN complex (Fig. 1F) . Reciprocally, immunoprecipitation of endogenous Usp9x precipitated components of the SMN complex (Fig. 1G) . In control blots, SMN and Usp9x were unable to immunoprecipitate the DUB Usp14 and Usp7, respectively ( Fig. 1F and G) . Collectively, these results demonstrate that Usp9x stably interacts with the SMN complex in cells.
Usp9x directly interacts with SMN
The SMN complex contains at least nine proteins including SMN, Gemins 2-8 and Unrip. We next sought to identify the protein(s) in the SMN complex that directly binds Usp9x. To do this, we overexpressed HA-Usp9x with a Flag-tagged component of the SMN complex in 293T cells. Immunoprecipitation, using the anti-Flag M2 antibody, followed by immunoblotting of HA revealed that Flag-SMN co-immunoprecipitated with HAUsp9x under a stringent washing condition containing 1.2 M NaCl ( Fig. 2A) . Despite all other overexpressed components of the SMN complex being efficiently immunoprecipitated, none of these proteins were able to co-immunoprecipitate HA-Usp9x ( Fig. 2A) . These results suggest that SMN directly interacts with Usp9x. To further confirm this, we purified recombinant GST-Usp9x from S. cerevisiae (Fig. 2B) and His 6 -SMN from E. coli (Fig. 2C) . In vitro GST pulldown assays showed that GST-Usp9x, but not GST, precipitated SMN (Fig. 2D) . Thus, Usp9x directly interacts with SMN.
Knockdown of Usp9x decreases the protein levels of SMN and the SMN complex
To examine whether Usp9x could regulate the protein levels of SMN, we established stable HeLa cell lines expressing either a control shRNA of green fluorescence protein (GFP) or one of the two distinct shRNAs of Usp9x. As shown in Fig. 3A , knockdown of Usp9x caused substantial reduction of protein levels of SMN, Gemins 2 and 8 in whole cell lysates. Protein levels of Gemin3 had mild decrease. In contrast, protein levels of Gemin4 and Sm didn't change at all. Similar results were obtained when A549 cells (Fig. 3B) , fibroblast cells of a type I SMA patient (Fig. 3C) or SH-SY5Y cells (Fig. S2) were applied for the knockdown experiments. Interestingly, simultaneous reduction of protein levels of SMN, Gemins 2, 3 and 8 were also observed in fibroblast cells derived from SMA patients compared to a normal carrier (54) (Fig. S3) . These results suggest that protein levels of several core components of the SMN complex are tightly co-regulated. Importantly, their protein levels can be regulated by Usp9x. The observed effect is specific to Usp9x because we found that siRNA Usp14, a DUB known to bind the 26S proteasome and regulate cellular Ub levels (55;56), had no effect on protein levels of SMN, Gemins 2, 3 and 8. In contrast, siRNA Usp9x caused reduction of their protein levels (Fig. S4) , despite being less efficient compared to shRNA-mediated Usp9x knockdown (Fig.  3A) . Together, these results demonstrate that Usp9x regulates the protein levels of several core components of the SMN complex.
Because knockdown of Usp9x decreases the total cellular protein levels of several components of the SMN complex, we hypothesized that the protein levels of the SMN complex decrease as well. To test this, we immunoprecipitated endogenous SMN to compare protein levels of the coimmunoprecipitated components of the SMN complex. The immunoprecipitated SMN was less in cell lysates from Usp9x knockdown cells than that from GFP knockdown cells (Fig. 3D ). For components of the SMN complex, protein levels of co-immunoprecipitated Gemins 4 and 8 and the Sm proteins were approximately 25% less than the SMN protein levels in Usp9x knockdown cells (Fig. 3D) , in which the protein levels of Gemin4 and Sm were not affected at all in whole cell lysates (Fig. 3A-C) . Thus, loss of Usp9x decreases protein levels of the SMN complex.
Loss of Usp9x impairs gems formation and SMN/coilin co-localization in the nucleus
Cellular fractionation from previous studies has shown that either no Usp9x or only a small portion of Usp9x was found in the nucleus (39;52). Immunofluorescence staining of endogenous Usp9x and SMN in HeLa cells revealed that both of them mostly localized in the cytoplasm and they partially co-localized in the perinuclear region; no Usp9x/SMN co-localization was observed in gems (Fig. 4A) . These results are consistent with a previous study using GFP-SMN (52). Thus, Usp9x might regulate the SMN complex stability in the cytoplasm. The SMN complex assembles in the cytoplasm and imports into the nucleus to form gems (21;57;58). We next examined whether knockdown of Usp9x affects gems formation. Immunofluorescence staining of SMN in either GFP or Usp9x knockdown HeLa cells found that loss of Usp9x significantly reduced the number of gems in the nucleus (Fig. 4B) . Quantification showed that, approximately 40% of Usp9x knockdown cells had no gems at all, while only 10% of GFP knockdown cells had no gems; the percentage of cells with one or two gems remained roughly the same between Usp9x and control knockdown cells. However, the percentage of cells with three or more gems was significantly decreased in Usp9x knockdown cells (Fig. 4C) . Furthermore, we found that knockdown of Usp9x significantly increased the percentage of cells that did not have SMN/coilin co-localization, approximately 50% of Usp9x knockdown cells vs. 20% of GFP knockdown cells (Fig. 4D and E) . Thus, loss of Usp9x significantly impairs gems formation and SMN/coilin co-localization in the nucleus.
SMN is predominantly mono-and diubiquitinated SMN was reported to be a ubiquitinated protein and a substrate of the proteasome (29;32). We performed denaturing immunoprecipitation to determine the ubiquitination status of SMN, which would obviate the possibility that observed ubiquitination comes from SMN's binding partners. In this assay, Flag-SMN and HA-Ub were expressed in 293T cells. Flag-SMN was immunoprecipitated from cell lysates using the anti-Flag M2 antibody under a denaturing condition (see Experimental Procedures). Immunoblotting of HA revealed that Flag-SMN was predominantly conjugated with mono-and di-Ub, and a small portion of SMN was conjugated with more than two Ub (Fig. 5A) . We noticed that monoubiquitination was the major modification of endogenous SMN as well in a previous study (29) . Interestingly, inhibition of the proteasome with MG132 did not obviously increase the ubiquitination levels of SMN (Fig. 5A ).
Usp9x deubiquitinates and protects SMN from degradation
We next sought to determine whether Usp9x deubiquitinates SMN. As revealed by denaturing immunoprecipitation (Fig. 5B) , overexpression of HA-Usp9x significantly reduced the protein levels of ubiquitinated SMN. In contrast, overexpression of HA-Usp9x(C1556A), a catalytically inactive mutant, had no effect on SMN ubiquitination. Consistent with this result, knockdown of Usp9x caused the accumulation of more monoubiquitinated SMN in HeLa cells compared to GFP knockdown cells, although the immunoprecipitated Flag-SMN in Usp9x knockdown cells was only 73% of that in GFP knockdown cells (Fig.  5C ). The lower amount of immunoprecipitated Flag-SMN in Usp9x knockdown cells is presumably because loss of Usp9x caused reduction of Flag-SMN as shown in the cell lysates (Fig. 5C) . We further performed an in vitro deubiquitination assay to determine if Usp9x deubiquitinates SMN. Ubiquitinated SMN was immunoprecipitated from cell lysates of 293T cells expressing Flag-SMN and HA-Ub. The immunoprecipitated Flag-SMN was washed with a stringent buffer containing 1% TX-100 and 1.35 M NaCl, and then incubated with or without recombinant GST-Usp9x, which exhibited DUB activity in an assay using K48-linked Ub 4 as the substrate (Fig. 5D ). In the absence of purified Usp9x, no deubiquitination of SMN was observed after incubation; addition of purified GST-Usp9x promoted SMN deubiquitination, which was abolished when the DUB activity of Usp9x was inhibited with Ub aldehyde (Fig. 5E ). These results demonstrate that Usp9x deubiquitinates SMN.
We next examined whether Usp9x functions to protect SMN from degradation using the cycloheximide (CHX)-chase assay. As shown in Fig.  5F -H, stable knockdown of Usp9x in HeLa cells significantly promoted degradation of endogenous SMN and Gemin8, and their degradation can be greatly inhibited by epoxomicin, a potent proteasome inhibitor (Fig. 5F ). In contrast, degradation of Gemins 2, 3, 4 and Sm were not affected in the same assay. Together, these results indicate that Usp9x deubiquitinates SMN and plays a role in mediating SMN degradation.
SMN ubiquitination might occur on multiple lysine residues
In an attempt to identify the lysine residue(s) of SMN that mediates SMN ubiquitination, we found that Flag-SMN(K0), a mutant in which all 22 lysine residues of SMN were mutated to arginines, was not able to be ubiquitinated (Fig. S5A) . However, introducing any lysine residue back into the SMN(K0) construct, individually or in certain combinations, partially regained SMN monoubiquitination as revealed by analyzing the cell lysates prepared from 293T cells overexpressing one of these constructs together with HA-Ub (data not shown). Thus, SMN ubiquitination is conjugated on lysine residues and the ubiquitination sites are promiscuous. Consistent with this, several large scale proteomics studies identified that endogenous SMN can be ubiquitinated on multiple lysine residues including lysines 41, 51, 186 and 209 (59) (60) (61) (62) . With confirming that SMN(K0) abolishes SMN ubiquitination, we examined whether ubiquitination mediates SMN degradation. To this end, we prepared HeLa cells stably expressing HA-SMN or HA-SMN(K0). CHX-chase assays showed that HA-SMN(K0) was resistant to degradation (Fig. S5B) . This result suggests that SMN degradation is Ub-dependent.
SMN∆7 is mostly polyubiquitinated and degraded by the proteasome SMN∆7, the main protein product of the SMN2 gene, is an unstable protein and a substrate of the proteasome (29) (30) (31) . It is unknown whether SMN∆7 degradation is Ub-dependent. We therefore assessed the ubiquitination status of SMN∆7. To do this, we expressed Flag-SMN∆7 and HAUb in 293T cells, which were either treated with MG132 to block proteasomal degradation or DMSO as a control. Denaturing immunoprecipitation assays demonstrated that SMN∆7 was conjugated with monoUb and short Ub chains in cells treated with DMSO, while polyubiquitination of SMN∆7 was apparent when cells were treated with MG132 (Fig. 6A) . Also, proteasome inhibition greatly increased protein levels of SMN∆7 (Fig. 6A) . The smeared high molecular weight species of SMN∆7 was resistant to a treatment with 6 M urea plus 2.5% SDS (Fig. 6B) , excluding the possibility that they were aggregated SMN∆7 conjugated with short Ub chains. Thus, in addition to being mono-and di-ubiquitinated, SMN∆7 can also be highly ubiquitinated and its protein and ubiquitination levels are sensitive to proteasome inhibition.
Usp9x does not deubiquitinate SMN∆7, nor does it regulate SMN∆7 degradation
Next, we examined whether Usp9x regulates SMN∆7 degradation. To our surprise, expressing HA-Usp9x did not reduce the ubiquitination levels of SMN∆7 in 293T cells (Fig. 6C) . Nor did Usp9x , a Usp9x deletion mutant that was able to deubiquitinate SMN (Fig. S6A ) and the SMA-causing SMN(A2G) mutant (Fig. S6B ), deubiquitinate SMN∆7 (Fig. S6C) . Thus, Usp9x likely doesn't deubiquitinate SMN∆7. Moreover, compared to control shRNA, knockdown of Usp9x had no effect on the protein half life of HA-SMN∆7 stably expressed in HeLa cells (Fig. 6D) . In contrast, knockdown of Usp9x promoted degradation of HA-SMN stably expressed in HeLa cells (Fig. S7) , similar as the effect on degradation of endogenous SMN (Fig. 5F and G) . Thus, we conclude that Usp9x does not regulate polyubiquitination and the protein half life of SMN∆7. One potential explanation for this is that Usp9x and SMN∆7 have different cellular localizations. Usp9x is mainly a cytoplasmic protein (39;52) . Previous studies have shown that the exon 7 in SMN encodes a cytoplasmic localization sequence, and SMN∆7 is largely confined to the nucleus in chick forebrain neurons (63) . Consistent with this, overexpressed Flag-SMN∆7 in HeLa cells was found to be predominantly in the nucleus existing as excess foci (Fig. 6E ).
Discussion
In this study, we found that Usp9x stably associated with the SMN complex via a direct interaction with SMN. Knockdown of Usp9x decreased protein levels of SMN, Gemins 2, 3 and 8 in several cultured mammalian cell lines. Consequently, protein levels of the SMN complex decreased and SMN nuclear localization was impaired. We also found that Usp9x deubiquitinated SMN, which was predominantly mono-and di-ubiquitinated. Moreover, knockdown of Usp9x decreased the protein half life of SMN in HeLa cells. Taken together, we propose that Usp9x directly interacts with and deubiquitinates SMN, which protects SMN from Ub-dependent degradation.
The protein levels of SMN, Gemins 2, 3 and 8 seem to be tightly co-regulated as observed by analysis of their protein levels in SMA patient cells (54) , as well as in Usp9x knockdown cells shown in this study. Usp9x-mediated regulation is likely exerted post-transcriptionally because RT-PCR analyses showed that the mRNA levels of all gene products of the SMN complex in Usp9x knockdown cells were similar as those in GFP knockdown cells (Fig. S8) . The CHX-chase experiments showed that knockdown of Usp9x promoted degradation of SMN and Gemin8, but not Gemins 2 and 3, although their protein levels de-creased when Usp9x was knocked down in several cell lines. Presumably, loss of SMN and/or Usp9x activates feedback loops to block Gemins 2 and 3 protein translation, and thus, reducing their protein levels without affecting their degradation. The accelerated Gemin8 degradation in Usp9x knockdown cells might result from the loss of its binding partner SMN. Interestingly, the extent of reduction of SMN and Gemins 2, 3 and 8 protein levels in the examined cell lines was different when Usp9x was knocked down (Fig. 3A-C and Fig. S2 ). This might be due to the fact that their cellular protein levels are different in these cell lines; and/or degradation of these proteins is differently regulated in these cell lines, such as having different E3 Ub ligases.
SMN was previously found to be a substrate of the proteasome (29;32). We found that SMN was predominantly mono-and di-ubiquitinated, with a small fraction of SMN was modified with three or more Ub (Fig. 5A) . In contrast, SMN∆7 was able to be highly polyubiquitinated and its protein and ubiquitination levels were significantly increased in response to proteasomal inhibition (Fig. 6A) . The 26S proteasome usually degrades polyubiquitinated proteins conjugated with at least tetraUb (64) . Mono-and oligo-ubiquitination (multiple mono-ubiquitinations) are also able to target proteins for proteasomal degradation (65) (66) (67) (68) (69) . However, monoUb and short Ub chains have much weaker proteasomal binding affinity than that of polyUb chains, this might explain why SMN∆7 is more rapidly degraded than SMN by the 26S proteasome. The reason for differential ubiquitination of SMN and SMN∆7 is not clear. On the one hand, conformational differences between SMN and SMN∆7 could alter their binding/accessibility/affinity to E3/E4 Ub ligases, which result in differential ubiquitination. Although the crystal structures of SMN and SMN∆7 are unknown, their structural differences have been clearly demonstrated in the aspect of selfassociation. The regions encoded by exons 2b and 6 mediate SMN oligomerization, which in turn mediates formation of the SMN complex (54;70). Oligomerization of SMN∆7 was found to be significantly impaired (54) . On the other hand, cellular localizations of SMN and SMN∆7 might contribute to their differential ubiquitination. SMN distributes in both the cytoplasm and the nucleus, whereas SMN∆7 is predominantly located in the nucleus (63) , as also shown in HeLa cells overexpressing Flag-SMN∆7 (Fig. 6E) . It is possible that SMN∆7 is polyubiquitinated and degraded in the nucleus. Because Usp9x is mainly a cytoplasmic protein, it is not surprising that Usp9x could not deubiquitinate and regulate degradation of nuclear SMN∆7. Future studies aiming to identify E3/E4 Ub ligases of SMN and SMN∆7 will provide further insights on why SMN and SMN∆7 are ubiquitinated and degraded differently.
One well-established function of SMN is to help assembly of snRNPs (21) (22) (23) (24) , core components of the spliceosome. However, whether SMA is caused by splicing defects is controversial. For instance, significant reduction of SMN protein levels to approximately 15% or less of normal levels caused reduction of snRNA levels, especially the minor snRNAs, and tissue-specific splicing defects in severe SMA mice (71) (72) (73) . However, the observed splicing defects in severe SMA mice could result from a secondary effect of cell injury as the disease progresses because one recent study found that no significant splicing defects were detected in postnatal day 1 or 7 SMA mice compared to littermate control mice, while splicing defects were observed in day 13 severe SMA mice (74) . In a Drosophila model, Smn null mutants displayed larval lethality and showed reductions of minor snRNAs. However no appreciable defects were found in the splicing of mRNAs containing minorclass introns (75) . In contrast, increased U12 minor intron retention in two genes in Drosophila expressing loss-of-function SMN 73Ao , which produces an unstable SMN protein, was detected. Moreover, Stasimon, encoded by one of these two genes, was found to regulate motor circuit function (76) . Apparently, the role of SMN in regulating gene splicing and whether splicing defects in a subset of genes directly cause SMA require further investigation. We have performed mRNA-Seq to probe the transcriptome in Usp9x or control knockdown HeLa and A549 cells. No obvious gene splicing differences were probed when compared the splicing events in Usp9x knockdown cells to those in control knockdown cells. This might be caused by the fact that the SMN protein levels in the Usp9x knockdown cells are not yet reduced to the threshold that would cause splicing defects; and/or the SMN protein levels are not critical for regulating gene splicing in these two cell lines.
SMA is caused by low SMN protein levels. It will be interesting to determine to what extent the SMN protein levels decrease in various tissues when Usp9x is completely ablated in animals. Ablation of FAM, the mouse ortholog of human Usp9x, results in embryonic lethality (41) and FAM was found to play an essential role in embryo development (77) . Conditional knockout of FAM in mice or deletion of Usp9x orthologs in other organisms might be useful to evaluate whether loss of Usp9x leads to SMA development in future studies.
Abbreviations SMA, spinal muscular atrophy; SMN, survival motor neuron; DUB, deubiquitination enzyme; CHX, cycloheximide; Ub, ubiquitin. Usp9x was affinity-purified and then subjected to MS analysis as described in the Experimental Procedure. Proteins with two or more spectral counts were listed. Total RNA was isolated from GFP and USP9x knockdown HeLa cells using TRIZOL reagent. First-strand cDNA was synthesized using 1 µg total RNA with Superscript II according to the manufacture's recommendations. PCR reactions were performed with gene-specific primer pairs and the PCR products were analyzed on 1% agarose gel. 
